Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. — Natural Product Compound Library | Innovative Drug Discovery | Spectral Intelligence | Micro-ED Analysis

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. Healthy Roots Biotechnology (Shenzhen) Co., Limited Joint Development

中文 EN

Home

Products

NP Database

Services

Tech Insights

About

Contact

中文 EN

Plant Sources

Structural Classes

Microbial Sources

Flagship Varieties

Synthetic Compounds

CAS No.	NAME	Molecular Formula	Molecular Weight	Purity	Price	2D Structure
1629249-33-7	GSK-3008348 HCl CC1=CC(=NN1C2=CC=CC(=C2)C(CC(=O)O)CN3CCC(C3)CCC4=NC5=C(CCCN5)C=C4)C.Cl	C₂₉H₃₈ClN₅O₂	524.1	98%	Click to inquire
1630808-89-7	(4-(4-(6-Fluorobenzo[d]oxazol-2-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone C1CC1(C(=O)N2CCN(CC2)C(=O)C3=CC=C(C=C3)C4=NC5=C(O4)C=C(C=C5)F)O	C₂₂H₂₀FN₃O₄	409.4	98%	Click to inquire
1631137-51-3	Protein degrader 1 TFA CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)C3CC(CN3C(=O)C(C(C)(C)C)N)O.C(=O)(C(F)(F)F)O	C₂₄H₃₁F₃N₄O₅S	544.6	98%	Click to inquire
1632051-40-1	Zuranolone CC1(CCC2C(C1)CCC3C2CCC4(C3CCC4C(=O)CN5C=C(C=N5)C#N)C)O	C₂₅H₃₅N₃O₂	409.6	98%	Click to inquire
1636180-98-7	Tarloxotinib bromide CN1C=NC(=C1C[N+](C)(C)CC=CC(=O)NC2=NC=C3C(=C2)C(=NC=N3)NC4=CC(=C(C=C4)Cl)Br)[N+](=O)[O-].[Br-]	C₂₄H₂₄BR₂ClN₉O₃	681.8	98%	Click to inquire
1637771-14-2	Alobresib CC1=C(C(=NO1)C)C2=CC(=C3C(=C2)NC(=N3)C4CC4)C(C5=CC=CC=N5)(C6=CC=CC=N6)O	C₂₆H₂₃N₅O₂	437.5	98%	Click to inquire
1642288-47-8	Mavacamten CC(C)N1C(=O)C=C(NC1=O)NC(C)C2=CC=CC=C2	C₁₅H₁₉N₃O₂	273.33	98%	Click to inquire
1642581-63-2	Glumetinib CN1C=C(C=N1)C2=CN3C(=NC=C3S(=O)(=O)N4C5=C(C=N4)N=CC(=C5)C6=CN(N=C6)C)C=C2	C₂₁H₁₇N₉O₂S	459.5	98%	Click to inquire
1652591-81-5	((3S,4R)-3-Amino-4-hydroxypiperidin-1-yl)(2-(1-(cyclopropylmethyl)-1H-indol-2-yl)-7-methoxy-1-methyl-1H-benzo[d]imidazol-5-yl)methanone hydrochloride CN1C2=C(C=C(C=C2OC)C(=O)N3CCC(C(C3)N)O)N=C1C4=CC5=CC=CC=C5N4CC6CC6.Cl	C₂₇H₃₂ClN₅O₃	510.0	98%	Click to inquire
1654725-02-6	N-(3-carbamoyl-5,5,7,7-tetramethyl-4,7-dihydro-5H-thieno[2,3-c]pyran-2-yl)-1H-pyrazole-3-carboxamide CC1(CC2=C(C(O1)(C)C)SC(=C2C(=O)N)NC(=O)C3=CC=NN3)C	C₁₆H₂₀N₄O₃S	348.4	98%	Click to inquire

GSK-3008348 HCl

C₂₉H₃₈ClN₅O₂ 524.1

(4-(4-(6-Fluorobenzo[d]oxazol-2-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone

C₂₂H₂₀FN₃O₄ 409.4

Protein degrader 1 TFA

Protein degrader 1 (TFA)

C₂₄H₃₁F₃N₄O₅S 544.6

C₂₅H₃₅N₃O₂ 409.6

Tarloxotinib bromide

Tarloxotinib bromide

C₂₄H₂₄BR₂ClN₉O₃ 681.8

C₂₆H₂₃N₅O₂ 437.5

MYK-461 (SAR-439152)

C₁₅H₁₉N₃O₂ 273.33

C₂₁H₁₇N₉O₂S 459.5

((3S,4R)-3-Amino-4-hydroxypiperidin-1-yl)(2-(1-(cyclopropylmethyl)-1H-indol-2-yl)-7-methoxy-1-methyl-1H-benzo[d]imidazol-5-yl)methanone hydrochloride

GSK484 hydrochloride

C₂₇H₃₂ClN₅O₃ 510.0

N-(3-carbamoyl-5,5,7,7-tetramethyl-4,7-dihydro-5H-thieno[2,3-c]pyran-2-yl)-1H-pyrazole-3-carboxamide

C₁₆H₂₀N₄O₃S 348.4

< Previous 1 2 3 4 5 6 7 8 9 10 ... (Current page 15624) 16106 Next >

All products and services are for scientific research only. They may not be used for human administration, nor are they supplied to individual consumers.

Address: Room B410, Virtual University Park Key Laboratory Building, No. 1 Yuexing 2nd Road, High-Tech Zone Community, Yuehai Subdistrict, Nanshan District, Shenzhen

Phone: 400-856-5689

Email: kehuaai@kehuaai.com

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd.

ICP Record No.: 粤ICP备2024241782号